Health Canada's Natural Health Products Directorate (NHPD) has issued its April monthly Communiqué highlighting the announcement from earlier this week that the use of 'NPN Pending' on product labels is prohibited and also advising that certificates of analysis are no longer required to provide proof that every lot or batch offered for sale has been approved by the company's quality assurance person. All that is now required a signed attestation from their quality assurance person stating that he or she has approved every lot, or batch of a natural health product.
Also in this month's Communiqué are modofication sot the compliance policy including qualifiers to two existing risk criteria (of the 13 originally proposed) and removed one risk criteria : "does not follow appropriate quality specifications and processes, such as Good Manufacturing Practices (GMPs)" which the Directorate says was a bridging measure until site license and GMP provisions were in force as of January 1, 2006. The Directorate has also modified three priority dates, moving numbers 4,5 and 6 each back one year. More details can be found at: http://www.hc-sc.gc.ca/dhp-mps/prodnatur/bulletins/communiques/communique_apr06_e.html.